Amyris (AMRS) Misses Q3 EPS by 6c

Amyris (NASDAQ: AMRS) reported Q3 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $8.84 million.

For earnings history and earnings-related data on Amyris (AMRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c